ArticleBiochemistry and biophysics reports2018

BCL2 inhibitor ABT-199 and JNK inhibitor SP600125 exhibit synergistic cytotoxicity against imatinib-resistant Ph+ ALL cells.

Chisato Inoue et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.